(RWAY) Runway Growth Finance - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US78163D1000

Senior Loans, Growth Stage

RWAY EPS (Earnings per Share)

EPS (Earnings per Share) of RWAY over the last years for every Quarter: "2020-09": 0.4, "2020-12": 0.68, "2021-03": 0.3, "2021-06": 0.35, "2021-09": 0.32, "2021-12": 0.28, "2022-03": 0.3, "2022-06": 0.35, "2022-09": 0.36, "2022-12": 0.45, "2023-03": 0.45, "2023-06": 0.49, "2023-09": 0.54, "2023-12": 0.45, "2024-03": 0.46, "2024-06": 0.37, "2024-09": 0.41, "2024-12": 0.39, "2025-03": 0.42, "2025-06": 0.38, "2025-09": 0,

RWAY Revenue

Revenue of RWAY over the last years for every Quarter: 2020-09: 11.821627, 2020-12: 21.836618, 2021-03: 10.539541, 2021-06: 8.242009, 2021-09: 12.299011, 2021-12: 20.630264, 2022-03: 4.874678, 2022-06: 0.91, 2022-09: 14.273972, 2022-12: 21.26674, 2023-03: 13.606, 2023-06: 23.872, 2023-09: 43.779, 2023-12: 22.016, 2024-03: 40.009, 2024-06: 34.193, 2024-09: 36.651, 2024-12: 59.876, 2025-03: 35.398, 2025-06: 33.635, 2025-09: null,

Description: RWAY Runway Growth Finance October 25, 2025

Runway Growth Finance Corp. (NASDAQ:RWAY) is a Business Development Company (BDC) that focuses on providing senior-secured loans to late-stage and growth-phase companies. Its investment mandate targets loan sizes between $10 million and $75 million, positioning the firm as a direct lender rather than an equity investor.

The BDC concentrates on sectors where technology-driven growth is accelerating, including electronic equipment and instruments, systems and application software, hardware, storage, and specialized consumer services. It also targets healthcare-related areas such as biotechnology, healthcare technology, and medical equipment, as well as business services like data processing, outsourced services, and human-resources platforms.

According to the most recent Form 10-K (Q2 2024), RWAY reported a net asset value (NAV) of roughly $450 million and a distribution yield of 6.2%, with an average leverage ratio of 1.2 ×. The portfolio’s weighted-average loan maturity is about 4.5 years, and the credit quality is anchored by senior-secured structures that typically command a 300–400 basis-point spread over LIBOR/SOFR. Key macro drivers include the current high-interest-rate environment, which widens spreads for senior-secured debt, and sector-specific tailwinds such as sustained AI-related capital expenditures and robust biotech financing pipelines.

For a deeper, data-driven look at RWAY’s loan composition, credit metrics, and scenario analysis, you may find the ValueRay research portal useful as a next step in your due-diligence process.

RWAY Stock Overview

Market Cap in USD 357m
Sub-Industry Asset Management & Custody Banks
IPO / Inception 2021-10-21

RWAY Stock Ratings

Growth Rating 45.1%
Fundamental 64.4%
Dividend Rating 87.6%
Return 12m vs S&P 500 -3.96%
Analyst Rating 3.67 of 5

RWAY Dividends

Dividend Yield 12m 14.86%
Yield on Cost 5y 19.14%
Annual Growth 5y 92.74%
Payout Consistency 88.8%
Payout Ratio 123.5%

RWAY Growth Ratios

Growth Correlation 3m -88.4%
Growth Correlation 12m 40%
Growth Correlation 5y 77.1%
CAGR 5y 7.35%
CAGR/Max DD 3y (Calmar Ratio) 0.28
CAGR/Mean DD 3y (Pain Ratio) 0.89
Sharpe Ratio 12m -0.18
Alpha 1.86
Beta 0.594
Volatility 20.83%
Current Volume 337.6k
Average Volume 20d 275.1k
Stop Loss 9.5 (-3.9%)
Signal 0.36

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (85.7m TTM) > 0 and > 6% of Revenue (6% = 9.93m TTM)
FCFTA 0.05 (>2.0%) and ΔFCFTA -12.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -6.19% (prev -4.50%; Δ -1.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 122.6m > Net Income 85.7m (YES >=105%, WARN >=100%)
Net Debt (-5.96m) to EBITDA (109.7m) ratio: -0.05 <= 3.0 (WARN <= 3.5)
Current Ratio 0.59 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (37.1m) change vs 12m ago -5.30% (target <= -2.0% for YES)
Gross Margin 68.17% (prev 74.84%; Δ -6.67pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 15.62% (prev 12.98%; Δ 2.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 0.34 (EBITDA TTM 109.7m / Interest Expense TTM 42.0m) >= 6 (WARN >= 3)

Altman Z'' -0.23

(A) -0.01 = (Total Current Assets 14.8m - Total Current Liabilities 25.1m) / Total Assets 1.04b
(B) -0.05 = Retained Earnings (Balance) -51.4m / Total Assets 1.04b
(C) 0.01 = EBIT TTM 14.4m / Avg Total Assets 1.06b
(D) -0.09 = Book Value of Equity -51.0m / Total Liabilities 542.4m
Total Rating: -0.23 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 64.42

1. Piotroski 5.0pt = 0.0
2. FCF Yield 5.74% = 2.87
3. FCF Margin 30.05% = 7.50
4. Debt/Equity 1.03 = 1.99
5. Debt/Ebitda -0.05 = 2.50
6. ROIC - WACC (= -3.32)% = -4.15
7. RoE 16.93% = 1.41
8. Rev. Trend 73.92% = 5.54
9. EPS Trend -64.94% = -3.25

What is the price of RWAY shares?

As of November 08, 2025, the stock is trading at USD 9.89 with a total of 337,589 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -0.60%, over three months by -5.90% and over the past year by +9.51%.

Is Runway Growth Finance a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Runway Growth Finance is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 64.42 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RWAY is around 11.78 USD . This means that RWAY is currently undervalued and has a potential upside of +19.11% (Margin of Safety).

Is RWAY a buy, sell or hold?

Runway Growth Finance has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold RWAY.
  • Strong Buy: 3
  • Buy: 0
  • Hold: 6
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the RWAY price?

Issuer Target Up/Down from current
Wallstreet Target Price 11.6 17%
Analysts Target Price 11.6 17%
ValueRay Target Price 12.7 27.9%

RWAY Fundamental Data Overview November 02, 2025

Market Cap USD = 357.4m (357.4m USD * 1.0 USD.USD)
P/E Trailing = 5.2606
P/E Forward = 6.8074
P/S = 2.535
P/B = 0.7427
P/EG = 1.1571
Beta = 0.594
Revenue TTM = 165.6m USD
EBIT TTM = 14.4m USD
EBITDA TTM = 109.7m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 515.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.96m USD (from netDebt column, last quarter)
Enterprise Value = 867.4m USD (357.4m + Debt 515.9m - CCE 5.96m)
Interest Coverage Ratio = 0.34 (Ebit TTM 14.4m / Interest Expense TTM 42.0m)
FCF Yield = 5.74% (FCF TTM 49.7m / Enterprise Value 867.4m)
FCF Margin = 30.05% (FCF TTM 49.7m / Revenue TTM 165.6m)
Net Margin = 51.74% (Net Income TTM 85.7m / Revenue TTM 165.6m)
Gross Margin = 68.17% ((Revenue TTM 165.6m - Cost of Revenue TTM 52.7m) / Revenue TTM)
Gross Margin QoQ = 75.83% (prev 48.51%)
Tobins Q-Ratio = 0.83 (Enterprise Value 867.4m / Total Assets 1.04b)
Interest Expense / Debt = 2.28% (Interest Expense 11.8m / Debt 515.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 11.4m (EBIT 14.4m * (1 - 21.00%))
Current Ratio = 0.59 (Total Current Assets 14.8m / Total Current Liabilities 25.1m)
Debt / Equity = 1.03 (Debt 515.9m / totalStockholderEquity, last quarter 498.9m)
Debt / EBITDA = -0.05 (Net Debt -5.96m / EBITDA 109.7m)
Debt / FCF = -0.12 (Net Debt -5.96m / FCF TTM 49.7m)
Total Stockholder Equity = 506.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.23% (Net Income 85.7m / Total Assets 1.04b)
RoE = 16.93% (Net Income TTM 85.7m / Total Stockholder Equity 506.1m)
RoCE = 1.42% (EBIT 14.4m / Capital Employed (Total Assets 1.04b - Current Liab 25.1m))
RoIC = 1.10% (NOPAT 11.4m / Invested Capital 1.03b)
WACC = 4.42% (E(357.4m)/V(873.3m) * Re(8.20%) + D(515.9m)/V(873.3m) * Rd(2.28%) * (1-Tc(0.21)))
Discount Rate = 8.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -2.47%
[DCF Debug] Terminal Value 69.77% ; FCFE base≈106.2m ; Y1≈69.7m ; Y5≈31.9m
Fair Price DCF = 16.89 (DCF Value 610.4m / Shares Outstanding 36.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -64.94 | EPS CAGR: -58.65% | SUE: -4.0 | # QB: 0
Revenue Correlation: 73.92 | Revenue CAGR: 36.57% | SUE: -0.05 | # QB: 0

Additional Sources for RWAY Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle